Bindu Kanapuru

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 8

Top Topics

Acute Myeloid Leukemia

Multiple Myeloma

Monoclonal Antibody

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Kavita Natrajan, Megha Kaushal, Bindu George, Bindu Kanapuru, Marc R Theoret
FDA Approval Summary: Ciltacabtagene Autoleucel for Relapsed or Refractory Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Kavita Natrajan, Megha Kaushal, Bindu George, Bindu Kanapuru, Marc R Theoret
FDA Approval Summary: Ciltacabtagene Autoleucel for Relapsed or Refractory Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Kavita Natrajan, Megha Kaushal, Bindu George, Bindu Kanapuru, Marc R Theoret
FDA Approval Summary: Ciltacabtagene Autoleucel for Relapsed or Refractory Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Joshua M Donaldson, Marjilla Seddiq, Michael J Fusco, Shyamli Singla, Gulsum E Pamuk, Rosa J Lee-Alonso, Bronwyn D Mixter, Kirsten B Goldberg, Laleh Amiri-Kordestani, R Angelo de Claro, Nicole Drezner, Nicole J Gormley, Bindu Kanapuru, Steven J Lemery, Lola A Fashoyin-Aje, Nicholas C Richardson, Harpreet Singh, Daniel L Suzman, Marc R Theoret, Paul G Kluetz, Richard Pazdur
Highlights of FDA Oncology Approvals in 2023: Bispecific T-cell Engagers, Pediatric Indications, and Inclusive Drug Development. Cancer discovery 13 (12) (2023)
Joshua M Donaldson, Marjilla Seddiq, Michael J Fusco, Shyamli Singla, Gulsum E Pamuk, Rosa J Lee-Alonso, Bronwyn D Mixter, Kirsten B Goldberg, Laleh Amiri-Kordestani, R Angelo de Claro, Nicole Drezner, Nicole J Gormley, Bindu Kanapuru, Steven J Lemery, Lola A Fashoyin-Aje, Nicholas C Richardson, Harpreet Singh, Daniel L Suzman, Marc R Theoret, Paul G Kluetz, Richard Pazdur
Highlights of FDA Oncology Approvals in 2023: Bispecific T-cell Engagers, Pediatric Indications, and Inclusive Drug Development. Cancer discovery 13 (12) (2023)
Andrea C Baines, Maryam Sarraf Yazdy, Yvette L Kasamon, Rachel Ershler, Emily Y Jen, Bindu Kanapuru, Nicholas C Richardson, Ashley Lane, Theresa Carioti, Marc R Theoret, Richard Pazdur, Nicole J Gormley
Minimal Residual Disease Data in Hematologic Malignancy Drug Applications and Labeling: An FDA Perspective. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Joshua M Donaldson, Marjilla Seddiq, Michael J Fusco, Shyamli Singla, Gulsum E Pamuk, Rosa J Lee-Alonso, Bronwyn D Mixter, Kirsten B Goldberg, Laleh Amiri-Kordestani, R Angelo de Claro, Nicole Drezner, Nicole J Gormley, Bindu Kanapuru, Steven J Lemery, Lola A Fashoyin-Aje, Nicholas C Richardson, Harpreet Singh, Daniel L Suzman, Marc R Theoret, Paul G Kluetz, Richard Pazdur
Highlights of FDA Oncology Approvals in 2023: Bispecific T-cell Engagers, Pediatric Indications, and Inclusive Drug Development. Cancer discovery 13 (12) (2023)
Joshua M Donaldson, Marjilla Seddiq, Michael J Fusco, Shyamli Singla, Gulsum E Pamuk, Rosa J Lee-Alonso, Bronwyn D Mixter, Kirsten B Goldberg, Laleh Amiri-Kordestani, R Angelo de Claro, Nicole Drezner, Nicole J Gormley, Bindu Kanapuru, Steven J Lemery, Lola A Fashoyin-Aje, Nicholas C Richardson, Harpreet Singh, Daniel L Suzman, Marc R Theoret, Paul G Kluetz, Richard Pazdur
Highlights of FDA Oncology Approvals in 2023: Bispecific T-cell Engagers, Pediatric Indications, and Inclusive Drug Development. Cancer discovery 13 (12) (2023)